Both in Pharmaceuticals
Latigo Biotherapeutics vs Alumis
Over the past year LTGO returned −36.8% and ALMS returned −33.3%; their daily moves had a correlation of 0.30.
LTGO −36.8% ALMS −33.3%Growth of $1, one year, split-adjusted
| Metric | LTGO | ALMS |
|---|---|---|
| Price | $14.00 | $6.12 |
| Market cap | $928.2M | $792.1M |
| Today | −5.15% | −3.01% |
| 1 month | −41.5% | −21.7% |
| 6 months | — | −75.5% |
| Year to date | — | −37.3% |
| 1 year | — | +26.2% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 107.1× |
| Net cash | — | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 180.2% |
| Short % of float | 1.7% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).